In addition, the results of relevant study revealed that except for controlling of autoimmune inflammation, celastrol has the potential of pharmacological treatment of obesity as leptin sensitizer in silico drug screening methods [53, 54]. The gene discussed is LEP; the disease is obesity disorder.